References
- Cretien P., Landry J. Enhanced constitutive expression of the 27-kDa heat shock proteins in heat-resistant variants from Chinese hamster cells. Journal of Cell Physiology 1988; 137: 157–166
- Hahn G.M., Shiu E.C. Protein synthesis, thermotolerance and step-down heating. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 159–164
- Hahn G.M., van Kersen I. Isolation and initial characterization of thermoresistant RIF tumor cell strains. Cancer Research 1988; 48: 1803–1807
- Kase K., Hahn G.M. Comparison of some responses to hyperthermia by normal human diploid cells and neoplastic cells from the same origin. European Journal of Cancer 1976; 12: 481–481
- Laszlo A., Li G.C. Heat resistant variants of Chinese hamster fibroblasts altered in expression of heat shock proteins. Proceedings of the National Academy of Sciences, U.S.A. 1985; 82: 8029–8033
- Li G.C. Elevated levels of 70,000 dalton heat shock protein in transiently thermotolerant Chinese hamster fibroblasts and in their stable heat resistant variants. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 165–177
- Li G.C., Cameron R.B., Sapareto S.A., Hahn G.M. Reinterpretation of Arrhenius analysis of cell inactivation by heat. National Cancer Institute Monograph 1982; 61: 111–113
- Rofstad E.K., Midthjell H., Brustad T. Heat sensitivity and thermotolerance in cells from five human melanoma xenographs. Cancer Research 1984; 44: 4347–4354
- Sapareto S.A., Dewey W.C. Thermal dose determination in cancer therapy. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 787–806
- Heat Shock from Bacteria to Man, M.J. Schlesinger, M. Ashburner, A. Tissieres. Cold Spring Harbor Laboratories. 1982
- Tveit K.M., Fodstad O., Johannessen J.V., Olsnes S. A human melanoma cell line established from xenograft in athymic mice. British Journal of Cancer 1980; 41: 724–733
- Twentyman P.R., Brown J.M., Gray J.W., Franko A.J., Scoles M.A., Kallman R.F. A new mouse tumor model system (RIF-1) for comparison of end-point studies. Journal of the National Cancer Institute 1980; 64: 594–604